Noradrenaline (Norepinephrine) Hospira Uk (Noradrenaline Tartrate)

Noradrenaline works by directly stimulating alpha‑1 adrenergic receptors, causing blood vessels to constrict, and beta‑1 receptors, increasing heart muscle contractility. This dual action raises systemic vascular resistance and cardiac output, leading to a rapid increase in arterial blood pressure, which is essential for managing life‑threatening hypotension.

The dose of Noradrenaline is individualized and set by the prescribing clinician based on the patient’s condition, blood pressure response, and monitoring data. Dosage is typically adjusted in micrograms per kilogram per minute via an intravenous infusion, with continuous hemodynamic monitoring to ensure safety and efficacy.

Safety data for Noradrenaline in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Clinicians must evaluate each case carefully and consider alternative therapies when appropriate.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details (including cold‑chain logistics if needed), and necessary import documentation.

Noradrenaline is often preferred for its balanced alpha‑1 and beta‑1 activity, providing both vasoconstriction and modest cardiac stimulation. Compared with agents like dopamine, it has a lower risk of tachyarrhythmias, and unlike phenylephrine, it also supports heart contractility, making it a first‑line choice for many shock states.

Noradrenaline injection solution should be stored at 2‑8 °C, protected from light, and must not be frozen or shaken. It should be kept in its original packaging until use, and any unused portion should be discarded according to local regulations after the recommended storage period.

Noradrenaline is administered intravenously, usually via a central venous catheter to reduce the risk of extravasation. The drug is supplied as a sterile solution that is diluted in a compatible carrier fluid and infused using a calibrated pump, allowing precise titration of the infusion rate.

Serious risks include severe hypertension, myocardial ischemia, tissue necrosis from extravasation, arrhythmias, and, in rare cases, cardiac arrest. Continuous hemodynamic monitoring and careful infusion site management are essential to detect and mitigate these potentially life‑threatening complications.

Noradrenaline is contraindicated in patients with known hypersensitivity to the drug or its excipients, and it should be used with extreme caution in individuals with uncontrolled hypertension, severe peripheral vascular disease, or those at high risk for tissue ischemia. Clinical judgment is required to assess suitability.